BI 144807

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 144807, covering 2013-05-16 to 2016-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration [Phase 2]